NCT06711003Recruiting
Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
Source: ClinicalTrials.gov · Last updated 2 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are: What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- First submitted
- 6 Nov 2024
- Start date
- 22 Oct 2024
- Primary completion date
- 15 May 2025
- Lead sponsor
- China Medical University Hospital
- Diseases
- Stroke
- NCT number
- NCT06711003
What you commit to
- Study type: Interventional
- Planned participants: 110
- From 22 Oct 2024 to the primary completion date, 15 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The presence of documented aortic aneurysm/dissection requiring surgical repair.
Other illness
- Patients with atrial fibrillation/arrhythmia.
- Within 2 weeks after cardiac catheterization or arterial puncture at the femoral artery puncture site.
- Decompensated heart failure (NYHA class 3 or 4).
- Persistent and uncontrolled hypertension (blood pressure persistently \>160/100 mmHg).
- Bleeding tendency.
- Active phlebitis/venous disease of the lower extremities.
- Severe vascular occlusive disease of the lower extremities.
Lab values
- Left ventricular ejection fraction (EF) \< 30%.
Other
- Moderate or severe aortic regurgitation.
- Pregnancy.
Who the study is looking for
- Patients with acute cerebrovascular disease, within 1 month after acute attack.
- Stable medical condition: (1). Neurological condition: The neurological condition has not deteriorated for more than 72 hours. (2). Vital signs including blood pressure, heartbeat, and body temperature are stable or controllable for more than 72 hours. (3). No complications such as infection, blood abnormalities, gastrointestinal bleeding, or stable or controllable after treatment.
- Those whose functional status is moderate to moderately severe functional impairment (MRS 3-4) and who are judged by the medical team to have active rehabilitation potential: (1). Have basic cognition, learning ability and willingness. (2) Have sufficient physical strength: able to maintain a sitting position on a wheelchair or bed edge for at least one hour with support. (3). Be able to actively participate in rehabilitation treatment plans.
- Aged over 20 years old
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| China Medical University Hospital Taichung East District Branch Coordinator of this site? Confirm its status | Taichung | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.